Compare ASML Holding NV (ASML) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ASML Holding NV vs State Street SPDR S&P Biotech ETF — how do they compare? ASML Holding NV trades at $1,828.28 (market cap $689.17B), while State Street SPDR S&P Biotech ETF trades at $158.2. The key difference: ASML Holding NV pays a 0.5% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| ASML | XBI | |
|---|---|---|
Market Cap | $689.17B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $1.99K | $164.28 |
52-Week Low | $725.85 | $86.92 |
Enterprise Value | $682.70B | — |
Dividend Yield | 0.5% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ASML Holding NV
Founded in 1984 and based in the Netherlands, ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photomask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a meaningful portion of the cost of making cutting-edge chips. Chipmakers require next-generation EUV lithography tools from ASML to continue past the 5-nanometer process node. ASML's products are used at every major semiconductor manufacturer, including Intel, Samsung, and TSMC.
Read more on ASML →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
